The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
A four‐gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis
Open accessAbstract
Objective: Improved outcome measures in systemic sclerosis (SSc) are critical to finding active therapeutics for this disease. The modified Rodnan skin thickness score (MRSS) is the current standard for evaluating skin disease in SSc, but it is not commonly used in the clinical setting, in part because it requires specialized training to perform accurately and consistently. The purpose of this study was to investigate whether skin gene expression might serve as a more objective surrogate outcome measure to supplement skin score evaluations. Methods: Skin RNAs from a group of patients with diffuse cutaneous SSc were studied for expression levels of genes known to be regulated by transforming growth factor β (TGFβ) and interferon (IFN). These levels were correlated with the MRSS, using multiple regression analyses to obtain best‐fit models. Results: Skin expression of the TGFβ‐regulated genes cartilage oligomeric matrix protein (COMP) and thrombospondin 1 (TSP‐1) correlated moderately well with the MRSS, but the addition of other TGFβ‐regulated genes failed to significantly improve best‐fit models. IFN‐regulated genes were also found to correlate with the MRSS, and the addition of interferon‐inducible 44 (IFI44) and sialoadhesin (Siglec‐1) to COMP and TSP‐1 in multiple regression analyses significantly improved best‐fit models, achieving an R 2 value of 0.89. These results were validated using an independent group of skin biopsy samples. Longitudinal scores using this 4‐gene biomarker indicated that it detects change over time that corresponds to changes in the MRSS. Conclusion: We describe a 4‐gene predictor of the MRSS and validate its performance. This objective measure of skin disease could provide a strong surrogate outcome measure for patient care and for clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Denton (2007) · doi:10.1002/art.22289 · Cited by 447
IL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-β Independent
Kaviratne, M., Hesse, M., Leusink, M., Cheever, A. W., Davies, S. J., McKerrow, J. H., Wakefield, L. M., Letterio, J. J., & Wynn, T. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4020 · Cited by 370
Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis
Kissin, E. Y., Merkel, P. A., & Lafyatis, R. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22186 · Cited by 123
Self-citation
Cited by
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
van Bon, L., Affandi, A. J., Broen, J., Christmann, R. B., Marijnissen, R. J., Stawski, L., Farina, G. A., Stifano, G., Mathes, A. L., Cossu, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1114576 · Cited by 453
Self-citationRevisiting the matricellular concept
Murphy-Ullrich, J. E., & Sage, E. H. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.07.005 · Cited by 392
Chakraborty, D., Šumová, B., Mallano, T., Chen, C.-W., Distler, A., Bergmann, C., Ludolph, I., Horch, R. E., Gelse, K., Ramming, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01236-6 · Cited by 356
Rice, L. M., Padilla, C. M., McLaughlin, S. R., Mathes, A., Ziemek, J., Goummih, S., Nakerakanti, S., York, M., Farina, G., Whitfield, M. L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77958 · Cited by 351
Self-citationTransforming growth factor β—at the centre of systemic sclerosis
Lafyatis, R. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.137 · Cited by 332
Self-citationThrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease
Murphy-Ullrich, J. E., & Suto, M. J. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.009 · Cited by 332
The Pathogenesis of Systemic Sclerosis
Katsumoto, T. R., Whitfield, M. L., & Connolly, M. K. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130312 · Cited by 313
Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin
Tabib, T., Huang, M., Morse, N., Papazoglou, A., Behera, R., Jia, M., Bulik, M., Monier, D. E., Benos, P. V., Chen, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24607-6 · Cited by 267
Self-citationAutoantibodies in systemic sclerosis
Mehra, S., Walker, J., Patterson, K., & Fritzler, M. J. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.05.011 · Cited by 252
PU.1 controls fibroblast polarization and tissue fibrosis
Wohlfahrt, T., Rauber, S., Uebe, S., Luber, M., Soare, A., Ekici, A., Weber, S., Matei, A.-E., Chen, C.-W., Maier, C., et al. (2019) · Nature · doi:10.1038/s41586-019-0896-x · Cited by 187
Mechanistic biomarkers for clinical decision making in rheumatic diseases
Robinson, W. H., Lindstrom, T. M., Cheung, R. K., & Sokolove, J. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.14 · Cited by 109
Stifano, G., Affandi, A. J., Mathes, A. L., Rice, L. M., Nakerakanti, S., Nazari, B., Lee, J., Christmann, R. B., & Lafyatis, R. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4598 · Cited by 86
Self-citation
Metadata
- Authors
- Farina, G., Lafyatis, D., Lemaire, R., & Lafyatis, R.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2010-01-28
- Volume
- 62
- Issue
- 2
- Pages
- 580-588
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2088656967
- Cited by
- 170
- References
- 4
- FWCI
- 9.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.